Consolidated Statement Of Profit Or Loss

Astellas Pharma Inc. - Filing #7604918

Concept 2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
Consolidated statement of profit or loss
Statement of profit or loss
Revenue
1,296,163,000,000 JPY
1,249,528,000,000 JPY
Cost of sales
253,009,000,000 JPY
246,063,000,000 JPY
Gross profit
1,043,154,000,000 JPY
1,003,465,000,000 JPY
Selling, general and administrative expenses
548,840,000,000 JPY
504,316,000,000 JPY
Other income
15,256,000,000 JPY
7,639,000,000 JPY
Other expenses
104,314,000,000 JPY
122,963,000,000 JPY
Operating profit (loss)
155,686,000,000 JPY
136,051,000,000 JPY
Finance income
6,149,000,000 JPY
11,608,000,000 JPY
Finance costs
4,949,000,000 JPY
2,335,000,000 JPY
Share of profit (loss) of investments accounted for using equity method
489,000,000 JPY
478,000,000 JPY
Profit (loss) before tax
156,886,000,000 JPY
145,324,000,000 JPY
Income tax expense
32,800,000,000 JPY
24,734,000,000 JPY
Profit (loss)
JPY
JPY
JPY
JPY
124,086,000,000 JPY
JPY
124,086,000,000 JPY
JPY
124,086,000,000 JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
120,589,000,000 JPY
JPY
120,589,000,000 JPY
JPY
120,589,000,000 JPY
JPY
Profit (loss) attributable to
Owners of parent
124,086,000,000 JPY
120,589,000,000 JPY
Earnings (loss) per share
Basic earnings (loss) per share
67.08
64.93
Diluted earnings (loss) per share
67.05
64.90

Talk to a Data Expert

Have a question? We'll get back to you promptly.